Skip to content

TruBridge, Inc. TBRG Payments to Develop Software

Payments to Develop Software at other companies

Phreesia logo
PhreesiaPHR
$3.24M-16.7%
Huron Consulting Group logo
Huron Consulting GroupHURN
$6.18M-7.5%
ROP
Roper Technologies, Inc.ROP
$15.4M+24.2%

Other financials

Income statement

See full
Revenue$86.3M-1.1%
Gross profit$47.9M+0.5%
Operating income$3.1M-62.5%
Net income$506.0K+10.2%
EPS (diluted)$0.030.0%

Balance sheet

See full
Cash & equivalents$35.4M+250%
Total debt$168.5M-1.4%
Total equity$178.7M+7.1%
Total assets$407.5M+4.8%

Cash flow

See full
Operating cash flow$15.5M+168%
CapEx$1.1M+201%
Free cash flow$14.4M+166%

Valuation

See full
Market cap$392.68M+16.7%
Enterprise value$525.72M+5.7%
P/E42.9×
P/S1.1×+0.2×

Profitability

See full
Gross margin53.2%+1.5pp
Operating margin4.5%+0.2pp
Net margin0.9%+0.5pp
FCF margin12.9%+2.2pp

Returns & leverage

See full
Return on equity1.8%+0.9pp
Debt / equity0.9×-0.1×
Current ratio1.8×+0.1×

Where this comes from

Reported directly by TruBridge, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToDevelopSoftware.

The official record: TruBridge, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about TruBridge, Inc.'s payments to develop software.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TruBridge, Inc.'s payments to develop software?
TruBridge, Inc. (TBRG) reported payments to develop software of $2.65M in Q1 2026.
How has TruBridge, Inc.'s payments to develop software changed year-over-year?
TruBridge, Inc.'s payments to develop software decreased by 33.5% year-over-year, from $3.98M to $2.65M.
What is the long-term trend for TruBridge, Inc.'s payments to develop software?
Over 4 years (2021 to 2025), TruBridge, Inc.'s payments to develop software has grown at a 14.0% compound annual growth rate (CAGR), from $9.37M to $15.81M.
What does payments to develop software mean?
This represents the cash outflows directed toward the internal development of software assets, including enhancements to EHR and RCM platforms. It reflects the company's commitment to capital investment in product innovation and long-term technological competitiveness. High levels of investment indicate a focus on future growth and service expansion within the healthcare market.